233 related articles for article (PubMed ID: 30005860)
21. [13-year history of scleroderma complicated by renal crisis and thrombotic microangiopathy treated with plasma exchange: A case report].
Minami T; Akazawa M; Kanda E; Nonomura Y
Nihon Rinsho Meneki Gakkai Kaishi; 2015; 38(2):116-20. PubMed ID: 26016639
[TBL] [Abstract][Full Text] [Related]
22. Exposure to ACE inhibitors prior to the onset of scleroderma renal crisis-results from the International Scleroderma Renal Crisis Survey.
Hudson M; Baron M; Tatibouet S; Furst DE; Khanna D;
Semin Arthritis Rheum; 2014 Apr; 43(5):666-72. PubMed ID: 24176729
[TBL] [Abstract][Full Text] [Related]
23. Complement activation and effect of eculizumab in scleroderma renal crisis.
Devresse A; Aydin S; Le Quintrec M; Demoulin N; Stordeur P; Lambert C; Gastoldi S; Pirson Y; Jadoul M; Morelle J
Medicine (Baltimore); 2016 Jul; 95(30):e4459. PubMed ID: 27472742
[TBL] [Abstract][Full Text] [Related]
24. [A retrospective clinical analysis of 16 patients with scleroderma renal crisis].
Zhou J; Xu D; Hou Y; Wang Q; Li M; Zeng X
Zhonghua Nei Ke Za Zhi; 2015 Feb; 54(2):125-9. PubMed ID: 25907843
[TBL] [Abstract][Full Text] [Related]
25. Scleroderma renal crisis in tropical region: two senegalese cases.
Cisse MM; Seck SM; Oumar DA; Fall K; Lemrabott AT; Diallo M; Faye M; Faye M; Niang A; Diouf B
Pan Afr Med J; 2015; 21():46. PubMed ID: 26405482
[TBL] [Abstract][Full Text] [Related]
26. [Scleroderma renal crisis].
Teixeira L; Servettaz A; Mehrenberger M; Noël LH; Guillevin L; Mouthon L
Presse Med; 2006 Dec; 35(12 Pt 2):1966-74. PubMed ID: 17159723
[TBL] [Abstract][Full Text] [Related]
27. Outcome of renal crisis in systemic sclerosis: relation to availability of angiotensin converting enzyme (ACE) inhibitors.
Steen VD; Costantino JP; Shapiro AP; Medsger TA
Ann Intern Med; 1990 Sep; 113(5):352-7. PubMed ID: 2382917
[TBL] [Abstract][Full Text] [Related]
28. [Renal involvement in patients with systemic sclerosis].
Bussone G; Noël LH; Mouthon L
Nephrol Ther; 2011 Jun; 7(3):192-9. PubMed ID: 21524952
[TBL] [Abstract][Full Text] [Related]
29. Scleroderma renal crisis: poor outcome despite aggressive antihypertensive treatment.
Walker JG; Ahern MJ; Smith MD; Coleman M; Pile K; Rischmueller M; Cleland L; Roberts-Thomson PJ
Intern Med J; 2003; 33(5-6):216-20. PubMed ID: 12752889
[TBL] [Abstract][Full Text] [Related]
30. Treatment of systemic sclerosis complications: what to use when first-line treatment fails--a consensus of systemic sclerosis experts.
Walker KM; Pope J; ;
Semin Arthritis Rheum; 2012 Aug; 42(1):42-55. PubMed ID: 22464314
[TBL] [Abstract][Full Text] [Related]
31. Renal complications and scleroderma renal crisis.
Denton CP; Lapadula G; Mouthon L; Müller-Ladner U
Rheumatology (Oxford); 2009 Jun; 48 Suppl 3():iii32-5. PubMed ID: 19487221
[TBL] [Abstract][Full Text] [Related]
32. Treatment of systemic sclerosis.
Allanore Y; Kahan A
Joint Bone Spine; 2006 Jul; 73(4):363-8. PubMed ID: 16495105
[TBL] [Abstract][Full Text] [Related]
33. [Successful use of angiotensin II receptor antagonist (losartan) in a patient with scleroderma renal crisis].
Hasegawa S; Iesato K; Tsukahara T; Yamamoto S; Kondou Y; Ogawa M; Ueda S
Nihon Jinzo Gakkai Shi; 2000 Feb; 42(2):60-5. PubMed ID: 10771577
[TBL] [Abstract][Full Text] [Related]
34. New therapeutic strategies for systemic sclerosis--a critical analysis of the literature.
Zandman-Goddard G; Tweezer-Zaks N; Shoenfeld Y
Clin Dev Immunol; 2005 Sep; 12(3):165-73. PubMed ID: 16295521
[TBL] [Abstract][Full Text] [Related]
35. Kidney crisis in systemic sclerosis.
Lewandowski B; Domysławska I; Klimiuk PA; Sierakowski S
Rocz Akad Med Bialymst; 2005; 50 Suppl 1():294-6. PubMed ID: 16119690
[TBL] [Abstract][Full Text] [Related]
36. [Clinical features and prognosis of patients with scleroderma renal crisis].
Roda-Safont A; Simeón-Aznar CP; Fonollosa-Plà V; Segarra-Medrano A; Vilardell-Tarrés M
Med Clin (Barc); 2011 Oct; 137(10):431-4. PubMed ID: 21596402
[TBL] [Abstract][Full Text] [Related]
37. Scleroderma renal crisis, still a life-threatening complication.
Teixeira L; Mahr A; Berezné A; Noël LH; Guillevin L; Mouthon L
Ann N Y Acad Sci; 2007 Jun; 1108():249-58. PubMed ID: 17893990
[TBL] [Abstract][Full Text] [Related]
38. Scleroderma Renal Crisis: Risk Factors for an Increasingly Rare Organ Complication.
Moinzadeh P; Kuhr K; Siegert E; Blank N; Sunderkoetter C; Henes J; Krusche M; Schmalzing M; Worm M; Schmeiser T; Günther C; Aberer E; Susok L; Riemekasten G; Kreuter A; Zeidler G; Juche A; Hadjiski D; Müller-Ladner U; Gaebelein-Wissing N; Distler JHW; Sárdy M; Krieg T; Hunzelmann N
J Rheumatol; 2020 Feb; 47(2):241-248. PubMed ID: 30936287
[TBL] [Abstract][Full Text] [Related]
39. Mortality and risk factors of scleroderma renal crisis: a French retrospective study of 50 patients.
Teixeira L; Mouthon L; Mahr A; Berezné A; Agard C; Mehrenberger M; Noël LH; Trolliet P; Frances C; Cabane J; Guillevin L;
Ann Rheum Dis; 2008 Jan; 67(1):110-6. PubMed ID: 17557890
[TBL] [Abstract][Full Text] [Related]
40. [Current treatment of systemic sclerosis. Part II. Vascular and antifibrotic treatment].
Sicińska J; Rudnicka L
Pol Merkur Lekarski; 2008 Aug; 25(146):196-200. PubMed ID: 18942347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
